ACRO BIOMEDICAL Changes Auditor; Prior Auditor Issued Going Concern Warning
ACBM filed a Corporate Governance and Compliance on light trading volume (0.1× avg).
Summary
ACRO BIOMEDICAL CO., LTD. changed its auditor, noting no disagreements, but disclosed that the previous auditor had issued a going concern warning.
Key Events · Corporate Governance and Compliance · ACBM
-
Auditor Dismissal
The company dismissed KCCW Accountancy Corp. as its independent registered public accounting firm on January 4, 2026.
-
New Auditor Engaged
Weinberg & Company was approved by the board of directors as the new independent registered accounting company on January 4, 2026.
-
No Disagreements Reported
The company stated there were no disagreements with KCCW on matters of accounting principles, financial statement disclosure, or auditing scope.
-
Prior Going Concern Warning
KCCW's audit reports for fiscal years ended December 31, 2024 and 2023, contained an explanatory paragraph regarding uncertainty about the company's ability to continue as a going concern.
Analysis · ACBM · Trade & Services
ACRO BIOMEDICAL CO., LTD. has dismissed its independent registered public accounting firm, KCCW Accountancy Corp., and engaged Weinberg & Company. While the company stated there were no disagreements on accounting principles or audit scope, KCCW's previous audit reports included an explanatory paragraph regarding the company's ability to continue as a going concern. This disclosure, even within an auditor change filing, highlights significant financial uncertainty for the micro-cap company, suggesting potential challenges to its long-term viability.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ACBM was trading at $0.02 on OTC in the Trade & Services sector, with a market capitalization of approximately $1.3M. The 52-week trading range was $0.00 to $9.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.